ImmunoZyme

Nazione: Australia

Lingua: inglese

Fonte: Department of Health (Therapeutic Goods Administration)

Principio attivo:

bromelains, Quantity: 50 mg; Ganoderma lucidum, Quantity: 125 mg; lipase, Quantity: 500 LipU; protease, Quantity: 24 Thousand HUT; Amylase, Quantity: 8 thousand DU; Grifola frondosa, Quantity: 125 mg

Commercializzato da:

Natural Bio Pty Limited

Forma farmaceutica:

Capsule, hard

Composizione:

Excipient Ingredients: microcrystalline cellulose; silicon dioxide; magnesium stearate; titanium dioxide; hypromellose; disodium edetate; potable water; gellan gum; potassium acetate

Via di somministrazione:

Oral

Indicazioni terapeutiche:

Maintain/support general health and wellbeing ; Aid/assist digestion/breakdown of dietary fat ; Aid/assist digestion of glucose/sugar/carbohydrates ; Aid/assist/helps digestion of (state nutrient) ; Helps enhance/improve/promote immune system function ; Maintain/support healthy immune system function

Dettagli prodotto:

Visual Identification: ;

Stato dell'autorizzazione:

Listed

Data dell'autorizzazione:

2018-02-07